| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4: Wilson Glynn, Director
Granted 75,000 Stock Option (Right to Buy) |
| 30 Sep 2026 |
Form 4: Alila Hector W, Director
Granted 50,000 Stock Option (Right to Buy) |
| 30 Sep 2026 |
Form 4: Melton Christopher, Director
Granted 50,000 Stock Option (Right to Buy) |
| 30 Sep 2026 |
Form 4: Galeta Christopher Matthew, Director
Granted 25,000 Stock Option (Right to Buy) |
| 30 Sep 2026 |
Form 4: Meadows Brian, Chief Financial Officer
Granted 25,000 Stock Option (Right to Buy) |
| 28 Jul 2026 |
Form 4: John Brian, Director
Disposed of 150,000 shares (Other Transaction) ($150K) |
| 27 Mar 2026 |
Form 4: Wilson Glynn, Director
Returned 1,500,000 shares to the issuer ($750K) |
| 27 Mar 2026 |
Form 4: John Brian, Director
Returned 1,250,000 shares to the issuer ($1.25M) |
| 16 Dec 2025 |
Form 4: Alila Hector W, Director
Granted 25,000 Stock Option (Right to Buy) |
| 15 Dec 2025 |
Form 4: John Brian, Director
Granted 100,000 Stock Option (Right to Buy) |
| 15 Dec 2025 |
Form 4: Melton Christopher, Director
Granted 25,000 Stock Option (Right to Buy) |
| 15 Dec 2025 |
Form 4: Galeta Christopher Matthew, Director
Granted 25,000 Stock Option (Right to Buy) |
| 15 Dec 2025 |
Form 4: Wilson Glynn, Director
Disposed of 172,592 shares (Grant/Award Acquisition) |
| 15 Dec 2025 |
Form 4: Moore Tyler Thomas, Chief Financial Officer
Disposed of 300,000 shares (Grant/Award Acquisition) |
Loading...